Skip to main content
    Educational content — not medical advice. Information on this page is for educational purposes only and is not a substitute for advice from a licensed physician. GLP-1 medications carry meaningful risks; speak with your doctor before starting any treatment. Compounded GLP-1 medications are not FDA-approved and clinical evidence is less robust than for FDA-approved branded products (Wegovy, Zepbound, Ozempic, Mounjaro). Read our full medical disclaimer · FDA on compounded GLP-1.
    Sexual Health

    PT-141Bremelanotide

    The brain-driven libido peptide — counters GLP-1 induced sexual side effects via central mechanism, not blood flow.

    How this page is reviewed

    Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).

    Last editorially reviewed
    Invalid Date

    Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.

    If you are considering a GLP-1 medication: consult a licensed physician familiar with your medical history. Do not start, stop, or change a prescription based on content from this site. Side effects, contraindications, and drug interactions are real and individual.

    What It Is

    PT-141 (bremelanotide) is a melanocortin receptor agonist that acts centrally in the brain to boost sexual desire and arousal. It works fundamentally differently from PDE5 inhibitors like Viagra or Cialis (which target peripheral blood flow). The branded version, Vyleesi, is FDA-approved for premenopausal hypoactive sexual desire disorder (HSDD) in women.

    Mechanism

    Activates melanocortin receptors (primarily MC4R) in the central nervous system, which influence sexual desire pathways. Effect is on "wanting" sex rather than mechanical arousal or erection — meaningfully different from PDE5 inhibitor mechanism.

    What Consumers Use It For

    • Restoring libido drop in women on GLP-1 medications (rapid weight loss can affect sexual desire)
    • Premenopausal HSDD (the FDA-approved Vyleesi indication)
    • Off-label use in men with desire-side issues that PDE5 inhibitors do not address

    Legal & Regulatory Status (May 2026)

    Vyleesi (branded bremelanotide) is FDA-approved for premenopausal HSDD in women. Compounded PT-141 is offered off-label via licensed telehealth with prescription. Off-label use in men is common but not FDA-approved.

    Telehealth Providers & Pricing

    Verified May 2026. Pricing varies by dose, plan length, and bundling. Always confirm directly with the provider before signup.

    Boston Medical Group

    Bremetide compounded via telehealth Rx

    Hone Health

    ~$130/mo (men-focused)

    SynergenX clinics

    Compounded protocols, varies by location

    TestDepot

    $459 for 8-week supply

    Vyleesi (branded)

    $0-$99 for 4 doses with savings card; $290/dose cash

    What the Evidence Actually Shows

    Phase 3 trials supported Vyleesi FDA approval in women — increases in satisfying sexual events vs placebo. Smaller off-label studies in men show libido improvement. Notably, this is a desire drug, not a performance drug — it does not produce erections directly.

    Typical Dosing Protocol

    Subcutaneous injection 1-2 mg taken approximately 45 minutes before anticipated activity. Vyleesi caps at 8 doses per month. Nasal spray formats exist but are less effective due to absorption variability. Most consumer protocols are as-needed rather than daily.

    Dosing should be confirmed by your prescribing physician — these are common consumer protocols, not medical advice.

    What Real Users Report

    Synthesized from Reddit (r/Peptides, r/Semaglutide, r/Tirzepatide) and forums, May 2025-2026:

    Reddit users in 2025-2026 frequently report restored "mental wanting" — particularly women on GLP-1 medications who experienced libido drop with rapid weight loss. The most common complaint is nausea, which can be severe enough to ruin the timing for some users. A minority report skin darkening at injection sites or flushing.

    Safety & Contraindications

    Common side effects: nausea (notable), flushing, headache, temporary skin darkening or hyperpigmentation. Avoid in patients with uncontrolled hypertension or cardiovascular disease. Black box warning for blood pressure elevation. Not for use during pregnancy.

    Best Reason to Add It

    Directly counters GLP-1-induced libido drop via central brain pathways that PDE5 inhibitors do not affect. For users experiencing desire-side effects (especially women), this is one of the only options.

    Biggest Red Flag

    Nausea side effects can be severe enough to derail the timing for many users. Not a quick-fix like PDE5 inhibitors and requires precise pre-activity dosing. Skin darkening can be persistent.

    Stacking note: Peptides are typically considered after a GLP-1 protocol is dialed in. If you have not started GLP-1 therapy yet, optimize that first. Compare GLP-1 telehealth pricing here before adding peptide protocols.

    Other Peptides for GLP-1 Stackers

    glp1comparehub

    Your independent guide to comparing GLP-1 medication providers. Find the right telehealth program for your weight-loss journey.

    Independent & Unbiased

    Medical Disclaimer: The information on this website is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any medication or treatment program. GLP-1 medications require a prescription and should only be used under medical supervision.

    Affiliate Disclosure: GLP1CompareHub.com is an independent review site. We may earn a commission when you click our links — at no additional cost to you. Our editorial recommendations are not influenced by commission rates. See our full affiliate disclosure.

    Compounded GLP-1 Notice: Compounded medications (compounded semaglutide, compounded tirzepatide) are NOT FDA-approved. They are produced by state-licensed 503A and 503B compounding pharmacies under specific FDA exemptions. Consult your prescriber about whether a branded FDA-approved medication or a compounded alternative is right for you.

    © 2026 GLP1CompareHub.com. All rights reserved.

    PT-141 2026: Evidence, Dosing, Cost & GLP-1 Stacking Guide | GLP1CompareHub